← FDA DRUG APPROVALS

FDA BLA · BLA761427

LEROCHOL

lerodalcibep-liga

Sponsor: LIB THERAPEUTICS, INC.

APPLICATION
BLA761427
TYPE
BLA
ORIGINAL APPROVAL
2025-12-12
LATEST ACTION
2025-12-12
ROUTE
SUBCUTANEOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

LEROCHOLPrescription
LERODALCIBEP-LIGA 300MG/1.2ML · INJECTABLE · INJECTION

Approval history

2025-12-12Type 1 - New Molecular Entity · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →